Stop TB Partnership

October 2008: Bagamoyo, Tanzania

Meeting Documents

2.08-0 Outcomes

• Decision Points [.pdf]
• Presentations from the meeting - 44 MB [.zip]

2.08-00 Welcome

• 2.08-00 Agenda [.doc]
• 2.08-00 Document List [.doc]

2.08-01 Administrative Session

• 2.08-01.0 Administrative Session [.doc]
• 2.08-01.1 Draft Agenda [.doc]
• 2.08-01.2 Executive Committee Selection [.doc]

2.08-02 Opening Ceremony

• 2.08-02.0 Opening Ceremony [.doc]
• 2.08-02.1 Biography [.doc]
• 2.08-02.2 Tanzania situational analysis [.pdf]

2.08-03 Review and Decisions on the future of Working Groups

• 2.08-03.0 Working Group Review Summary [.doc]
• 2.08-03.1 A DOTS Expansion [.doc]
• 2.08-03.1 A1 GLI [.doc]
• 2.08-03.1 A2 TB & Poverty [.doc]
• 2.08-03.1 A3 Childhood TB [.doc]
• 2.08-03.1 A4 PPM [.doc]
• 2.08-03.1 B TB HIV [.doc]
• 2.08-03.1 B1 TB Infection Control [.doc]
• 2.08-03.1 C MDR TB [.doc]
• 2.08-03.1 D ACSM [.doc]
• 2.08-03.1 D1 ACSM Future Discussion Note [.doc]
• 2.08-03.1 D1 ACSM Global level [.doc]
• 2.08-03.1 D2 ACSM Country level [.doc]
• 2.08-03.1 D2 Advocacy Advisory Committee and Network [.doc]
• 2.08-03.1 E New Drugs [.pdf]
• 2.08-03.1 F New Diagnostics [.doc]
• 2.08-03.1 G New Vaccines [.doc]

2.08-04 Global Fund and Collaboration with TB TEAM

• 2.08-04.0 Global Fund and TB Team Summary [.doc]

2.08-05 Calendar of Events (2009)

• 2.08-05.0 Calendar of Events [.doc]
• 2.08-05.1 2009 Advocacy Calendar [.xls]

2.08-06 Partners Forum 2009

• 2.08-06.0 Partners' Forum 2009 [.doc]
• 2.08-06.1 Partners Forum Structure [.xls]
• 2.08-06.2 Partners' Forum Agenda Explanation [.ppt]

2.08-07 Impact Assessment Taskforce

• 2.08-07.0 Impact Measurement Summary [.doc]

2.08-08 Engaging the Business Sector Constituency

• 2.08-08.0 Business Engagement Summary [.doc]

2.08-09 MDR-TB Meeting of 27 high burden countries

• 2.08-09.0 MDR Meeting Summary [.doc]

2.08-10 2nd line drugs management and supply

• 2.08-10.0 2nd-line Drugs Summary [.doc]
• 2.08-10.1 2nd line drugs Background Paper [.pdf]

2.08-11 Rolling out diagnostics in the field

• 2.08-11.0 Diganostics and GLI in the field [.doc]
• 2.08-11.1 GLI Synopsis FINAL [.pdf]
• 2.08-11.2 Line Probe Assays [.pdf]
• 2.08-11.3 DST policy [.pdf]

2.08-12 Global Plan Progress Report

• 2.08-12.0 Global Plan Progress Summary [.doc]

2.08-13 Roundtable on TB-HIV

• 2.08-13.0 TB-HIV Roundtable [.doc]
• 2.08-13.1 Call For Action [.pdf]

2.08-14 Implementation of the Work Plan 2008

• 2.08-14.0 Work Plan Implementation Summary [.doc]
• 2.08-14.1 Workplan Implemenation Technical Explanation [.doc]
• 2.08-14.2A Secretariat Workplan Implementation [.xls]
• 2.08-14.2B GDF Workplan Implementation [.xls]
• 2.08-14.3 Ex Comm Minutes Evaluation [.doc]

2.08-15 Closing Session

• 2.08-15.0 Closing Session [.doc]